Skip to main content

Advertisement

Table 1 Table

From: Safety of anti-TNF therapy: 10 year experience in pediatric patients from a single tertiary center

  Etanercept Infliximab Adalimumab
Number of treatments 105 43 12
Mean age at onset,ys (SD) 11.2 (4.8) 12.5 (4.1) 16.4 (3.8)
Exposure time (pts-year) 246,5 82,7 9,2
Adverse events 75 76 5
Incidente rate AE 0.3 0.9 0.5
SAE (incidente rate) 2 (0.008) 5 (0.06) 0 (0)
Opportunistic infections (Tuberculosis) 1 2 0
Discontinuation due to AE n (%) 5 (4.8) 13 (30.2) 0